Moreover, Perez et al. [22] found that a post-radiotherapy CEA level <5 ng/mL was a favorable prognostic factor for rectal cancer and was associated with increased rates of earlier disease staging and complete tumor regression. The gene discussed is CEACAM5; the disease is rectal cancer.